October 29, 2016

Matt Ervin, CEO of MedicaSafe

Matt Ervin, CEO of MedicaSafe, has developed a breakthrough technology in medication adherence, potentially having a positive effect on the current national crisis in opioid addiction. Below, he discusses the state of outpatient therapy today, shares his thoughts on the prescription drug abuse epidemic and explains how MedicaSafe can help.       […]
October 29, 2016

Inspirion Closes Deal with Japanese Giant

Inspirion Delivery Sciences LLC and Daiichi Sankyo, Inc. have entered into an agreement aimed at commercializing Inspirion’s new abuse-deterrent, pain management opioid, MorphaBond.  The agreement comes on the heels of FDA approval of the drug.  Daiichi is considered a leader in the U.S. pharmaceutical market. The company focuses on the […]